The presence of parathyroid hormone related peptide (PTHrP) was studied in 20 patients with pituitary adenomas and one patient with pituitary adenocarcinoma. PTHrP expression was shown in almost all of the pituitary adenomas (95%) and in 100% (n = 7) growth hormone producing pituitary adenomas.
peptide in human pituitary tumours M Ito, H Enomoto, T Usa, M C Villadolid, A Ohtsuru, H Namba, I Sekine, S Yamashita Abstract The presence of parathyroid hormone related peptide (PTHrP) was studied in 20 patients with pituitary adenomas and one patient with pituitary adenocarcinoma. PTHrP expression was shown in almost all of the pituitary adenomas (95%) and in 100% (n = 7) growth hormone producing pituitary adenomas. A metastatic lesion from a pituitary growth hormone producing adenocarcinoma revealed strongly expressed PTHrP. It was weakly detected in normal pituitary cells in all of the specimens (n = 10). There was no significant correlation, however, between PTHrP expression and the clinical or pathological features of growth hormone producing tumours. Apart from an important role in the physiological function of the pituitary gland, PTHrP may be closely related to somatotroph tumorigenicity. (3 Clin Pathol 1993; 48:682-683) York, USA) overnight at 4°C. The slides were sequentially incubated with alkaline phosphatase conjugated goat anti-mouse immunoglobulin antibodies. The alkaline phosphatase reaction was demonstrated using a BCIP/NBT (BRL, Gaithersburg, Maryland). In all cases, Copenhagen immunohistochemical staining of growth hormone, prolactin, adrenocorticotropic hormone, thyroid stimulating and follicular stimulating hormone (Dakopatts (ABC)) was performed in serial sections using the avidin-biotin-peroxidase complex method with diaminobenzidine as the chromogenic substrate (Vectastain Elite kits, Burlingham, California), after exposure to a 0 3% solution of hydrogen peroxide in absolute methanol to block endogenous peroxidase. Cultured cells producing PTHrP (human squamous cell carcinoma cell line) served as internal positive controls in immunostaining for PTHrP. Negative controls were prepared by replacing the primary antibody with non-immune serum.
Various growth factors occur in the human pituitary gland.' These growth factors may be involved in the gland's endocrine function regardless of whether they are actually produced by pituitary cells. Parathyroid hormone related peptide (PTHrP) was originally isolated from human tumour cells derived from patients with hypercalcaemia of malignancy,2 3 but the PTHrP gene is widely expressed in normal and neoplastic tissues and functions in a paracrine and an autocrine manner. 4 Recently our preliminary data have demonstrated the presence of PTHrP mRNA in rat pituitary glands and in rat GH, pituitary tumour cells. We therefore extended our study to (C) The metastatic growth hormone producing tumour cells exhibit varying degrees ofpositivity for growth hormone (ABC method).
suggesting the co-localisation of growth hormone and PTHrP in the same mammosomatotroph cell. This was supported by evidence of strong positivity of PTHrP in growth hormone producing pituitary tumours. There was only one case of invasive growth hormone producing adenocarcinoma,5 and the strongest positivity of PTHrP staining in this metastatic tumour suggests that a worsening prognosis and metastatic activity of somatotroph tumours are closely related to the induction of PTHrP gene by a mechanism similar to that of other PTHrP producing tumours. group.bmj.com on June 16, 2017 -Published by
